Hypercalciuria associated with high dietary protein intake is not due to acid load.

Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol (2013) 1.51

Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab (2012) 1.41

Potassium and health. Adv Nutr (2013) 0.98

Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics (Sao Paulo) (2012) 0.90

Nutrition in calcium nephrolithiasis. J Transl Med (2013) 0.81

Diet: from food to stone. World J Urol (2014) 0.78

Metaphylaxis, diet and lifestyle in stone disease. Arab J Urol (2012) 0.77

Relevance of dietary protein concentration and quality as risk factors for the formation of calcium oxalate stones in cats. J Nutr Sci (2014) 0.76

Re: hypercalciuria associated with high dietary protein intake is not due to acid load. J Urol (2012) 0.75

Fad diets and their effect on urinary stone formation. Transl Androl Urol (2014) 0.75

Impact of Increasing Dietary Calcium Levels on Calcium Excretion and Vitamin D Metabolites in the Blood of Healthy Adult Cats. PLoS One (2016) 0.75

Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med (2002) 8.79

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87

Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med (1994) 3.62

Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr (2009) 2.08

Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 1.94

Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah. J Bone Miner Res (2004) 1.94

Intakes of calcium, phosphorus, and protein, and physical-activity level are related to radial bone mass in young adult women. Am J Clin Nutr (1993) 1.84

The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest (1966) 1.80

Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis (2002) 1.68

Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia. J Am Soc Nephrol (2006) 1.43

The impact of dietary protein on calcium absorption and kinetic measures of bone turnover in women. J Clin Endocrinol Metab (2004) 1.37

Protein consumption and bone fractures in women. Am J Epidemiol (1996) 1.32

Mechanism and molecular determinant for regulation of rabbit transient receptor potential type 5 (TRPV5) channel by extracellular pH. J Biol Chem (2003) 1.27

Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women. J Clin Endocrinol Metab (2008) 1.25

Effects of metabolic acidosis and alkalosis on sodium and calcium transport in the dog kidney. Kidney Int (1979) 1.22

The influence of dietary protein intake on specific renal functions in normal man. J Lab Clin Med (1954) 1.21

Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20

Potassium bicarbonate attenuates the urinary nitrogen excretion that accompanies an increase in dietary protein and may promote calcium absorption. J Clin Endocrinol Metab (2008) 1.19

Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr (2003) 1.15

Dietary protein and calcium interact to influence calcium retention: a controlled feeding study. Am J Clin Nutr (2009) 1.08

Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women. J Clin Endocrinol Metab (2005) 1.05

Phosphate decreases urine calcium and increases calcium balance: a meta-analysis of the osteoporosis acid-ash diet hypothesis. Nutr J (2009) 1.05

The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond) (1979) 1.04

Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron (1999) 1.03

Dietary protein and bone health. Proc Nutr Soc (2003) 1.03

Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr (1981) 1.01

Dietary protein intake and bone mass in women. Calcif Tissue Int (1996) 0.97

JESS, A joint expert speciation system-I. Raison d'être. Talanta (1991) 0.94

Relationship of dietary intake of sulphur amino-acids to urinary excretion of inorganic sulphate in man. Nature (1965) 0.93

Nephrolithiasis. J Am Soc Nephrol (1998) 0.90

Hypercalciuria from acid load: renal mechanisms. J Nephrol (2006) 0.88

Role of the sulfur-containing amino acids in protein-induced hypercalciuria in men. J Nutr (1981) 0.88

Comparative effects of oral aromatic and branched-chain amino acids on urine calcium excretion in humans. Osteoporos Int (2007) 0.88

Citrate and renal calculi: new insights and future directions. Am J Kidney Dis (1991) 0.86

Contrasting effects of various potassium salts on renal citrate excretion. J Clin Endocrinol Metab (1991) 0.86

Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate. J Urol (2009) 0.85

Metabolic, but not respiratory, acidosis increases bone PGE(2) levels and calcium release. Am J Physiol Renal Physiol (2001) 0.83

The relation between the ultrafiltrable calcium fraction and blood pH and concentrations of total plasma calcium, albumin, and globulin. Clin Chem (1998) 0.83

Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1990) 0.83

Protein diet and hypercalciuria. Kidney Int (2004) 0.80

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50

Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol (2010) 4.59

Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol (2013) 3.41

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol (2009) 3.30

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J (2010) 2.91

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int (2004) 2.89

Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Arch Intern Med (2010) 2.89

Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab (2006) 2.73

Association of urinary pH with body weight in nephrolithiasis. Kidney Int (2004) 2.67

Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int (2010) 2.50

Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23

Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. Hypertension (2012) 2.23

Autophagy genes protect against Salmonella typhimurium infection and mediate insulin signaling-regulated pathogen resistance. Proc Natl Acad Sci U S A (2009) 2.21

Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02

Association of Hyperchloremia With Hospital Mortality in Critically Ill Septic Patients. Crit Care Med (2015) 1.93

Echocardiographic indices do not reliably track changes in left-sided filling pressure in healthy subjects or patients with heart failure with preserved ejection fraction. Circ Cardiovasc Imaging (2011) 1.86

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82

Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int (2002) 1.78

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol (2013) 1.78

Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int (2003) 1.76

Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71

Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail (2011) 1.69

Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis (2002) 1.68

Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J Am Soc Nephrol (2003) 1.67

CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab (2007) 1.66

β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care (2012) 1.66

Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol (2006) 1.66

Klotho: a novel regulator of calcium and phosphorus homeostasis. Pflugers Arch (2011) 1.63

Effect of dietary modification on urinary stone risk factors. Kidney Int (2005) 1.61

Open-cell versus closed-cell stent design differences in blood flow velocities after carotid stenting. J Vasc Surg (2009) 1.58

Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol (2011) 1.57

Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol (2005) 1.54

Circadian variation in urine pH and uric acid nephrolithiasis risk. Nephrol Dial Transplant (2007) 1.51

Low prevalence of mutations in known loci for autosomal dominant hypercholesterolemia in a multiethnic patient cohort. Circ Cardiovasc Genet (2012) 1.51

Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51

Biochemical profile of stone-forming patients with diabetes mellitus. Urology (2003) 1.51

Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol (2009) 1.50

Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus. J Rheumatol (2002) 1.49

Etiological role of estrogen status in renal stone formation. J Urol (2002) 1.48

Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46

Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44

Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab (2009) 1.44

ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes (2005) 1.43

Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol (2010) 1.41

Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes. Am J Physiol Renal Physiol (2013) 1.40

Stimulated growth hormone concentrations in obese pediatric patients with mild and severe insulin resistance: a pilot study. J Pediatr Endocrinol Metab (2010) 1.39

Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol (2013) 1.39

Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better? Diabetes Care (2009) 1.38

Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol (2009) 1.36

Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol (2005) 1.31

Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol (2008) 1.27

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int (2013) 1.27

Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26

Functional sympatholysis is impaired in hypertensive humans. J Physiol (2011) 1.25

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology (2008) 1.24

Lipid- and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci U S A (2004) 1.23

Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol (2010) 1.22

Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med (2003) 1.21

Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch (2008) 1.21

Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol (2002) 1.20

Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens (2004) 1.20

Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf (2007) 1.19

Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis (2006) 1.19

Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system. Mol Cell Proteomics (2008) 1.18

Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int (2004) 1.18

Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort. J Diabetes Complications (2007) 1.15

Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature. Endocr Pract (2006) 1.14

Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr (2007) 1.14

Secreted klotho and chronic kidney disease. Adv Exp Med Biol (2012) 1.13

Role of c-SRC and ERK in acid-induced activation of NHE3. Kidney Int (2002) 1.13

Nephrolithiasis in children. Pediatr Nephrol (2005) 1.12

Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells. Am J Physiol Renal Physiol (2004) 1.11

Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int (2003) 1.11

Klotho and chronic kidney disease. Contrib Nephrol (2013) 1.11

Predictors of fracture risk and bone mineral density in men with prostate cancer on androgen deprivation therapy. J Osteoporos (2011) 1.10

CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol (2008) 1.10

Ontogeny of NHE8 in the rat proximal tubule. Am J Physiol Renal Physiol (2007) 1.10